NOVAVAX INC Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Novavax Inc quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • Novavax Inc Entity Common Stock, Shares Outstanding for the quarter ending October 31, 2024 was 160M shares, a 34.8% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 160M +41.4M +34.8% Oct 31, 2024 10-Q 2024-11-12
Q2 2024 160M +65.7M +69.6% Jul 31, 2024 10-Q 2024-08-08
Q1 2024 140M +54.1M +62.7% Apr 30, 2024 10-Q 2024-05-10
Q3 2023 119M +40.3M +51.3% Oct 31, 2023 10-Q 2023-11-09
Q2 2023 94.4M +16.2M +20.7% Jul 31, 2023 10-Q 2023-08-08
Q1 2023 86.3M +8.17M +10.5% Apr 30, 2023 10-Q 2023-05-09
Q3 2022 78.5M +2.9M +3.83% Oct 31, 2022 10-Q 2022-11-09
Q2 2022 78.2M +3.73M +5.01% Jul 31, 2022 10-Q 2022-08-09
Q1 2022 78.1M +4.04M +5.46% Apr 30, 2022 10-Q 2022-05-10
Q3 2021 75.6M +11.9M +18.8% Oct 31, 2021 10-Q 2021-11-05
Q2 2021 74.5M +13.2M +21.6% Jul 31, 2021 10-Q 2021-08-05
Q1 2021 74.1M +22.6M +43.8% Apr 27, 2021 10-K/A 2021-04-30
Q3 2020 63.7M +37.1M +140% Oct 31, 2020 10-Q 2020-11-10
Q2 2020 61.3M +37.4M +156% Jul 31, 2020 10-Q 2020-08-10
Q1 2020 51.5M -390M -88.3% Mar 6, 2020 10-K 2020-03-11
Q3 2019 26.6M -356M -93.1% Oct 31, 2019 10-Q 2019-11-07
Q2 2019 23.9M -359M -93.7% Jul 31, 2019 10-Q 2019-08-07
Q1 2019 441M +97.6M +28.4% Mar 12, 2019 10-K 2019-03-18
Q3 2018 383M +69.2M +22.1% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 383M +88.4M +30.1% Aug 3, 2018 10-Q 2018-08-08
Q1 2018 344M +61.1M +21.6% Mar 9, 2018 10-K 2018-03-14
Q3 2017 314M +42.4M +15.6% Oct 31, 2017 10-Q 2017-11-07
Q2 2017 294M +23M +8.48% Jul 31, 2017 10-Q 2017-08-08
Q1 2017 283M +11.8M +4.37% Apr 30, 2017 10-Q 2017-05-08
Q3 2016 271M +1.39M +0.51% Oct 31, 2016 10-Q 2016-11-09
Q2 2016 271M +1.55M +0.57% Jul 31, 2016 10-Q 2016-08-09
Q1 2016 271M +2.75M +1.03% Apr 30, 2016 10-Q 2016-05-05
Q3 2015 270M +31.4M +13.2% Oct 31, 2015 10-Q 2015-11-09
Q2 2015 270M +31.2M +13.1% Jul 31, 2015 10-Q 2015-08-10
Q1 2015 268M +59M +28.2% Apr 30, 2015 10-Q 2015-05-07
Q3 2014 238M +30M +14.4% Oct 31, 2014 10-Q 2014-11-06
Q2 2014 238M +85.7M +56.1% Jul 31, 2014 10-Q 2014-08-07
Q1 2014 209M +61.1M +41.3% Mar 6, 2014 10-K 2014-03-12
Q3 2013 209M +60.6M +40.9% Oct 31, 2013 10-Q 2013-11-12
Q2 2013 153M +19M +14.2% Jul 30, 2013 10-Q 2013-08-08
Q1 2013 148M +26.4M +21.7% Mar 4, 2013 10-K 2013-03-12
Q3 2012 148M +33M +28.7% Oct 31, 2012 10-Q 2012-11-09
Q2 2012 134M +18.6M +16.1% Jul 31, 2012 10-Q 2012-08-09
Q1 2012 122M Mar 8, 2012 10-K 2012-03-14
Q3 2011 115M Oct 31, 2011 10-Q 2011-11-08
Q2 2011 115M Jul 31, 2011 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.